Skip to main content
Premium Trial:

Request an Annual Quote

Metabolomics Firm Metabolon Raises $13.1M

NEW YORK (GenomeWeb News) – Metabolomics firm Metabolon today announced it has completed a Series D financing round that raised $13.1 million.

New investor Keating Capital participated in the round, which also included existing investors Sevin Rosen Funds, Aurora Funds, Harris & Harris Group; Syngenta Ventures, Fletcher Spaght, and Fulcrum Financial Partners.

The Research Triangle Park, NC-based firm raised $12.3 million in a Series C round two years ago.

John Ryals, president and CEO of Metabolon, said in a statement that the funds will be used to support growth of its Metabolytics division, which provides biochemical profiling services, as well as ongoing development of Metabolon's diagnostics products portfolio.

The company, which had been primarily a service business, moved into the diagnostics space earlier this year. Its first diagnostic test, called Quantose, targets insulin-resistance and is in final CLIA validation, Todd Lynch, Metabolon's CFO said in an e-mail to GenomeWeb Daily News. He added that the test is anticipated to launch by the end of the year.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.